Ignite Creation Date:
2024-05-06 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05703464
Status:
TERMINATED
Last Update Posted:
2023-03-09
First Post:
2023-01-19
Brief Title:
Elobixibat for Chronic Constipation Without Defecation Desire
Sponsor:
International University of Health and Welfare
Organization:
International University of Health and Welfare
Study Overview
Official Title:
A Multicenter Single-group Open-label Before-and-after Study Confirming Recovery of Defecation Desire by Administration of Elobixibat in Patients With Chronic Constipation
Status:
TERMINATED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Personal reason
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients of chronic constipation without defecation desire will be orally administered elobixibat 10 mg once daily before meals for 4 weeks The primary endpoint of the prepost comparative study will be the percentage of improvement in bowel movements from Week 2 of the observation period at Week 4 of the treatment period
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None